Literature DB >> 28892452

Science in Emergency Response at CDC: Structure and Functions.

John Iskander1, Dale A Rose1, Neelam D Ghiya1.   

Abstract

Recent high-profile activations of the US Centers for Disease Control and Prevention (CDC) Emergency Operations Center (EOC) include responses to the West African Ebola and Zika virus epidemics. Within the EOC, emergency responses are organized according to the Incident Management System, which provides a standardized structure and chain of command, regardless of whether the EOC activation occurs in response to an outbreak, natural disaster, or other type of public health emergency. By embedding key scientific roles, such as the associate director for science, and functions within a Scientific Response Section, the current CDC emergency response structure ensures that both urgent and important science issues receive needed attention. Key functions during emergency responses include internal coordination of scientific work, data management, information dissemination, and scientific publication. We describe a case example involving the ongoing Zika virus response that demonstrates how the scientific response structure can be used to rapidly produce high-quality science needed to answer urgent public health questions and guide policy. Within the context of emergency response, longer-term priorities at CDC include both streamlining administrative requirements and funding mechanisms for scientific research.

Entities:  

Mesh:

Year:  2017        PMID: 28892452      PMCID: PMC5594391          DOI: 10.2105/AJPH.2017.303951

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  14 in total

1.  From SARS to 2009 H1N1 influenza: the evolution of a public health incident management system at CDC.

Authors:  Stephen S Papagiotas; Mark Frank; Sherrie Bruce; Joseph M Posid
Journal:  Public Health Rep       Date:  2012 May-Jun       Impact factor: 2.792

2.  Research as a part of public health emergency response.

Authors:  Nicole Lurie; Teri Manolio; Amy P Patterson; Francis Collins; Thomas Frieden
Journal:  N Engl J Med       Date:  2013-03-28       Impact factor: 91.245

3.  Zika Virus and Birth Defects--Reviewing the Evidence for Causality.

Authors:  Sonja A Rasmussen; Denise J Jamieson; Margaret A Honein; Lyle R Petersen
Journal:  N Engl J Med       Date:  2016-04-13       Impact factor: 91.245

4.  Zika Virus 6 Months Later.

Authors:  Thomas R Frieden; Anne Schuchat; Lyle R Petersen
Journal:  JAMA       Date:  2016-10-11       Impact factor: 56.272

5.  Zika virus in semen: lessons from Ebola.

Authors:  Lawrence J Purpura; Mary J Choi; Pierre E Rollin
Journal:  Lancet Infect Dis       Date:  2016-09-19       Impact factor: 25.071

6.  CDC Grand Rounds: Modeling and Public Health Decision-Making.

Authors:  Leah S Fischer; Scott Santibanez; Richard J Hatchett; Daniel B Jernigan; Lauren Ancel Meyers; Phoebe G Thorpe; Martin I Meltzer
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-09       Impact factor: 17.586

7.  Possible Association Between Zika Virus Infection and Microcephaly - Brazil, 2015.

Authors:  Lavinia Schuler-Faccini; Erlane M Ribeiro; Ian M L Feitosa; Dafne D G Horovitz; Denise P Cavalcanti; André Pessoa; Maria Juliana R Doriqui; Joao Ivanildo Neri; Joao Monteiro de Pina Neto; Hector Y C Wanderley; Mirlene Cernach; Antonette S El-Husny; Marcos V S Pone; Cassio L C Serao; Maria Teresa V Sanseverino
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-01-29       Impact factor: 17.586

Review 8.  CDC's Emergency Management Program activities - worldwide, 2003-2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-09-06       Impact factor: 17.586

9.  Defining the syndrome associated with congenital Zika virus infection.

Authors:  Anthony Costello; Tarun Dua; Pablo Duran; Metin Gülmezoglu; Olufemi T Oladapo; William Perea; João Pires; Pilar Ramon-Pardo; Nigel Rollins; Shekhar Saxena
Journal:  Bull World Health Organ       Date:  2016-06-01       Impact factor: 9.408

10.  Roles and contributions of pharmacists in regulatory affairs at the Centers for Disease Control and Prevention for public health emergency preparedness and response.

Authors:  Tina R Bhavsar; Hye-Joo Kim; Yon Yu
Journal:  J Am Pharm Assoc (2003)       Date:  2010 Mar-Apr 1
View more
  5 in total

1.  Integrating the Food and Drug Administration Office of the Coordinated Outbreak Response and Evaluation Network's foodborne illness outbreak surveillance and response activities with principles of the National Incident Management System.

Authors:  Sharon Seelman; Stelios Viazis; Sheila Pack Merriweather; Tami Craig Cloyd; Megan Aldridge; Kari Irvin
Journal:  J Emerg Manag       Date:  2021 Mar-Apr

2.  Changes in the Scientific Information Environment During the COVID-19 Pandemic: The Importance of Scientific Situational Awareness in Responding to the Infodemic.

Authors:  John K Iskander; Katherine M Bianchi
Journal:  Health Secur       Date:  2020-12-17

3.  Using a Health Literacy Analytic Framework to Explore Zika Virus and Reproductive Health.

Authors:  Erika L Thompson; Cheryl A Vamos; Langdon G Liggett; Stacey B Griner; Ellen M Daley
Journal:  Health Lit Res Pract       Date:  2018-04-12

4.  Experience and practice of the Emergency Operations Center, Chinese Center for Disease Control and Prevention: a case study of response to the H7N9 outbreak.

Authors:  Fan Ding; Qun Li; Lian-Mei Jin
Journal:  Infect Dis Poverty       Date:  2021-01-06       Impact factor: 4.520

Review 5.  An initiative of cooperation in Zika virus research: the experience of the ZIKABRA study in Brazil.

Authors:  Silvana Pereira Giozza; Ximena Pamela Díaz Bermúdez; Edna Oliveira Kara; Guilherme Amaral Calvet; Ana Maria Bispo de Filippis; Marcus Vinícius Guimarães Lacerda; Camila Helena Aguiar Bôtto-Menezes; Marcia da Costa Castilho; Rafael Freitas Oliveira Franca; Armando Menezes Neto; Casey Storme; Noemia S Lima; Kayvon Modjarrad; Maria Cristina Pimenta de Oliveira; Gerson Fernando Mendes Pereira; Nathalie Broutet
Journal:  BMC Public Health       Date:  2021-03-23       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.